Medical Device Single Audit Program (MDSAP)

Intertek is a recognized MDSAP Auditing Organization (AO). 

What is MDSAP?

The Medical Device Single Audit Program was developed by a group of medical device regulators to allow recognized third-party auditors to conduct a single audit of a medical device manufacturer that will cover ISO 13485:2003 and their respective regulatory requirements.

More information and documents about the International Medical Device Regulators Forum (IMDRF) and MDSAP are available on the IMDRF website and on the FDA’s website. 

What regulatory authorities are currently participating in the MDSAP program?  

The regulatory authorities that are currently participating in the MDSAP Program are:

  • Australia - TGA
  • Brazil - ANVISA
  • Canada - Health Canada
  • U.S. - FDA
  • Ministry of Health, Labour and Welfare (MHLW) and the Japanese Pharmaceuticals and Medical Devices Agency (PMDA)

How will regulatory authorities utilize MDSAP audit reports? 

Australia:  The Therapeutics Goods Administration - TGA will use an MDSAP audit report as part of the evidence that is assessed for compliance with medical device market authorization requirements unless the medical device is otherwise excluded or exempt from these requirements or if current policies restrict the use of MDSAP audit reports.

Brazil:  The Brazilian National Health Surveillance Agency – ANVISA will utilize the outcomes of the program, including the reports, to constitute an important input on ANVISA’s pre-market and post-market assessment procedures, providing, when applicable, key information that are expected to support regulatory technical evaluation on these issues.

  Health Canada – HC will use a MDSAP audit as part of their Canadian Medical Device Conformity Assessment System (CMDCAS) certification program.  Upon the successful conclusion of the pilot, Health Canada's intent is to implement the Medical Device Single Audit Program as the mechanism to achieve regulatory compliance for quality management system requirements in Canada.

Japan:  MHLW and PMDA will utilize these audit reports in both premarket and periodical post market audit under regulations in Japan. Undergoing the MDSAP Pilot audits is expected .to reduce some burden on Japanese regulatory processes.

United States:
  U.S. Food and Drug Administration’s Center for Devices and Radiological Health – FDA will accept the MDSAP audit reports as a substitute for FDA routine inspections.  Inspections conducted “For Cause” or “Compliance Follow-up” by FDA will not be affected by this program.  Moreover, this MDSAP program would not apply to any necessary pre-approval or post approval inspections for Premarket Approval (PMA) applications or to decisions under section 513(f)(5) of the Act (21 U.S.C. 360c(f)(5)) concerning the classification of a device.”

Extract from: MDSAP Pilot Announcement  


The MDSAP Pilot Program ran for three years; from January 1, 2014 to December 31, 2016. Upon review of the MDSAP Final Pilot Report, the MDSAP Regulatory Authority Council decided that the MDSAP Pilot was a successful demonstration of the effectiveness of the program. 

On December 4, 2015, Health Canada announced that it intends to implement MDSAP as the sole mechanism for manufacturers to demonstrate compliance with the quality management system requirements of the Medical Devices Regulations. MDSAP will replace the current Canadian Medical Devices Conformity Assessment System (CMDCAS) program, even in situations when a manufacturer intends to sell only in Canada. The implementation began at the conclusion of the Pilot which was on January 1, 2017, and will span a period of two years. During this two year period, Health Canada will accept certificates issued under both CMDCAS and MDSAP. As of January 1, 2019, only MDSAP certificates will be accepted.

In the beginning of 2017, Intertek was recognized as a MDSAP Auditing Organization (AO).

How can manufacturers participate and prepare for an MDSAP audit? 

Manufacturers should implement applicable requirements and may perform internal audits using the MDSAP audit documents (Audit Model and Companion document) available on the FDA website.

Communication, audit planning and scheduling are essential for success. Please let your scheduler know as soon as possible of your intent to be audited to MDSAP requirements. MDSAP audits may be performed during the scheduled annual visit or during a special visit. 

Medical Device Single Audit Program (MDSAP) Frequently Asked Questions


Need help or have a question?

+61 1300 046 837
+44 (0) 116 296 1620
+1 800 810 1195
+46 8 750 03 33
Asia Pacific
+86 21 50273066